California Award Recipient: 'Promising' Results from Chinese Stem Cell Trial for Knee Arthritis
Cellular Biomed has a four-year U.S. history
A Chinese biomedical firm that popped up last month with an award from the $3 billion California stem cell agency is working with the University of Southern California and Children's Hospital in Los Angeles to ready an arthritis therapy for a clinical trial in the United States.
The publicly traded enterprise i…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.